Complications during pregnancy: Pathology review

11,186views

test

00:00 / 00:00

Complications during pregnancy: Pathology review

before placement

before placement

Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Aortic dissections and aneurysms: Pathology review
Pericardial disease: Pathology review
Endocarditis: Pathology review
Hypertension: Pathology review
Shock: Pathology review
Vasculitis: Pathology review
Cardiac and vascular tumors: Pathology review
Dyslipidemias: Pathology review
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Diabetes insipidus and SIADH: Pathology review
Multiple endocrine neoplasia: Pathology review
Congenital gastrointestinal disorders: Pathology review
Esophageal disorders: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Inflammatory bowel disease: Pathology review
Malabsorption syndromes: Pathology review
Diverticular disease: Pathology review
Appendicitis: Pathology review
Gastrointestinal bleeding: Pathology review
Colorectal polyps and cancer: Pathology review
Pancreatitis: Pathology review
Gallbladder disorders: Pathology review
Jaundice: Pathology review
Viral hepatitis: Pathology review
Cirrhosis: Pathology review
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Pigmentation skin disorders: Pathology review
Acneiform skin disorders: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Vesiculobullous and desquamating skin disorders: Pathology review
Skin cancer: Pathology review
Back pain: Pathology review
Rheumatoid arthritis and osteoarthritis: Pathology review
Seronegative and septic arthritis: Pathology review
Gout and pseudogout: Pathology review
Systemic lupus erythematosus (SLE): Pathology review
Scleroderma: Pathology review
Sjogren syndrome: Pathology review
Bone disorders: Pathology review
Bone tumors: Pathology review
Myalgias and myositis: Pathology review
Neuromuscular junction disorders: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Congenital neurological disorders: Pathology review
Headaches: Pathology review
Seizures: Pathology review
Cerebral vascular disease: Pathology review
Traumatic brain injury: Pathology review
Spinal cord disorders: Pathology review
Dementia: Pathology review
Central nervous system infections: Pathology review
Movement disorders: Pathology review
Demyelinating disorders: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors: Pathology review
Neurocutaneous disorders: Pathology review
Congenital renal disorders: Pathology review
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Renal failure: Pathology review
Nephrotic syndromes: Pathology review
Nephritic syndromes: Pathology review
Urinary incontinence: Pathology review
Urinary tract infections: Pathology review
Kidney stones: Pathology review
Renal and urinary tract masses: Pathology review
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Cervical cancer: Pathology review
Vaginal and vulvar disorders: Pathology review
Benign breast conditions: Pathology review
Breast cancer: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Choanal atresia
Laryngomalacia
Allergic rhinitis
Nasal polyps
Upper respiratory tract infection
Sinusitis
Laryngitis
Retropharyngeal and peritonsillar abscesses
Bacterial epiglottitis
Nasopharyngeal carcinoma
Respiratory distress syndrome: Pathology review
Cystic fibrosis: Pathology review
Pneumonia: Pathology review
Tuberculosis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review
Coronary artery disease: Clinical
Heart failure: Clinical
Syncope: Clinical
Pericardial disease: Clinical
Valvular heart disease: Clinical
Infective endocarditis: Clinical
Cardiomyopathies: Clinical
Hypertension: Clinical
Hypercholesterolemia: Clinical
Diabetes mellitus: Clinical
Hyperthyroidism: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Hypothyroidism and thyroiditis: Clinical
Thyroid nodules and thyroid cancer: Clinical
Pituitary adenomas and pituitary hyperfunction: Clinical
Hypopituitarism: Clinical
Cushing syndrome: Clinical
Adrenal insufficiency: Clinical
Adrenal masses and tumors: Clinical
MEN syndromes: Clinical
Esophageal disorders: Clinical
Esophagitis: Clinical
Gastroesophageal reflux disease (GERD): Clinical
Peptic ulcers and stomach cancer: Clinical
Gastroparesis: Clinical
Diarrhea: Clinical
Malabsorption: Clinical
Inflammatory bowel disease: Clinical
Colorectal cancer: Clinical
Diverticular disease: Clinical
Anal conditions: Clinical
Gastrointestinal bleeding: Clinical
Gallbladder disorders: Clinical
Pancreatitis: Clinical
Jaundice: Clinical
Viral hepatitis: Clinical
Cirrhosis: Clinical
Immunodeficiencies: Clinical
Fever of unknown origin: Clinical
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Anemia: Clinical
Leukemia: Clinical
Thrombocytopenia: Clinical
Lymphoma: Clinical
Bleeding disorders: Clinical
Myeloproliferative neoplasms: Clinical
Thrombophilia: Clinical
Plasma cell disorders: Clinical
Blood products and transfusion: Clinical
Pneumonia: Clinical
Urinary tract infections: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Bites and stings: Clinical
Hypernatremia: Clinical
Hyponatremia: Clinical
Hyperkalemia: Clinical
Hypokalemia: Clinical
Metabolic and respiratory acidosis: Clinical
Metabolic and respiratory alkalosis: Clinical
Toxidromes: Clinical
Medication overdoses and toxicities: Pathology review
Environmental and chemical toxicities: Pathology review
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Nephritic and nephrotic syndromes: Clinical
Asthma: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Cystic fibrosis: Clinical
Diffuse parenchymal lung disease: Clinical
Venous thromboembolism: Clinical
Acute respiratory distress syndrome: Clinical
Pleural effusion: Clinical
Pneumothorax: Clinical
Lung cancer: Clinical
Joint pain: Clinical
Rheumatoid arthritis: Clinical
Seronegative arthritis: Clinical
Systemic lupus erythematosus (SLE): Clinical
Sjogren syndrome: Clinical
Inflammatory myopathies: Clinical
Vasculitis: Clinical
Antihistamines for allergies
Glucocorticoids
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Positive inotropic medications
Loop diuretics
Antiplatelet medications
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Laxatives and cathartics
Antidiarrheals
Acid reducing medications
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Thrombolytics
Hematopoietic medications
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Osmotic diuretics
Carbonic anhydrase inhibitors
Potassium sparing diuretics
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Osteoporosis medications

Assessments

USMLE® Step 1 questions

0 / 12 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 12 complete

A 25-year-old woman comes to the clinic due to a progressive cough accompanied by mild hemoptysis. During the past 2 weeks, she has been experiencing non-productive cough, pelvic pressure, and mild vaginal bleeding. Six weeks ago, the patient had an abortion at 15 weeks gestation, and since then, her menstrual period had not yet returned. She is in good health, and she does not smoke or use alcohol or illicit drugs. She is sexually active with her male partner and currently does not use contraception. Temperature is 37.0°C (98.6°F), pulse is 100/min, and blood pressure is 135/85 mmHg. On physical examination, the uterus is soft and mildly enlarged. Vaginal examination shows minimal blood at the vaginal vault. The cervix is closed, non-erythematous. An x-ray of the chest is obtained and shows multiple, rounded nodules of variable size scattered throughout the lungs. Which of the following findings is most specific for this patient’s conditions? 

Transcript

Watch video only

26 year-old Effie is brought to the emergency department with severe lower abdominal pain and bloody vaginal discharge that began a few hours ago. Her last menstrual period was 7 weeks ago. She has been sexually active with multiple partners and uses condoms on occasion. Her past medical history is significant for pelvic inflammatory disease. On examination, her blood pressure is 80/40 mmHg and her pulse is 130 beats per minute. She is pale and her extremities are cold and clammy. Next to her, there’s also 37-year-old Kate who came in noting an abrupt onset of abdominal pain and continuous vaginal bleeding. She is going through week 28 of her fourth pregnancy and was involved in a car crash a couple of hours ago, but did not immediately seek medical care. On presentation, fetal heart rate and movement are significantly diminished. Laboratory studies reveal low platelets, prolonged PT and PTT and elevated d-dimers. Peripheral blood smear shows schistocytes.

Based on their initial presentation, both Effie and Kate have a form of pregnancy complication.

Now, the most common medical complication of pregnancy is hypertensive disorders of pregnancy. These are diseases that cause high blood pressure during pregnancy, either a systolic blood pressure higher than 140 mmHg, or a diastolic blood pressure higher than 90 mmHg, or both. So, when hypertension is diagnosed before 20 weeks gestation, it’s usually chronic hypertension, meaning that it’s not due to pregnancy.

After 20 weeks gestation, new onset hypertension without proteinuria or damage to other organs is gestational hypertension. Now if hypertension gets severe, meaning systolic blood pressure of 160 mmHg or greater and/or diastolic blood pressure of 110 mmHg or greater, it can often lead to organ damage. One key thing to look out for is the presence of proteinuria, or excessive amounts of protein in the urine, which is a marker of kidney damage. Other affected organs include the brain and liver.

Now, if the hypertension coexists with proteinuria or other organ dysfunction, then it’s called preeclampsia. Preeclampsia is more common during a person’s first pregnancy, in pregnancies with multiple gestations, or in mothers 35 years or older. Other risk factors include having pre-existing hypertension, diabetes, chronic kidney disease or autoimmune disorders like the antiphospholipid syndrome. The exact reason why preeclampsia develops is unclear, but a high yield pathophysiologic feature though is the development of an abnormal placenta. Normally, during pregnancy, the spiral arteries dilate to 5-10 times their normal size and develop into large uteroplacental arteries that can deliver large quantities of blood to the developing fetus. In preeclampsia, these uteroplacental arteries undergo fibrosis, causing them to narrow, which means less blood gets to the placenta. This hypoperfused placenta starts releasing proinflammatory proteins. These then get into the mother’s circulation and cause the endothelial cells that line her blood vessels to become dysfunctional. Endothelial cell dysfunction causes vasoconstriction or narrowing of the blood vessels and also affects the kidneys in a way that makes them retain more salt, both of which result in hypertension. Vasoconstriction will also lead to reduced blood flow to the kidneys, which are particularly susceptible to ischemia and can cause glomerular damage leading to proteinuria.

The high blood pressure can also cause placental abruption, where the placenta detaches prematurely from the uterine wall. Next, the increased pressure inside blood vessels can cause endothelial injury which leads to the formation of lots of tiny thrombi in the microvasculature. This process uses up massive amounts of platelets so there’s an increased risk of bleeding. To make things worse, these tiny blood clots are like large rocks in a river and damages the red blood cells trying to move past them, so there’s extrinsic hemolytic anemia. Specifically, red blood cells get split into smaller fragments called schistocytes. And bare in mind that these schistocytes are visible on peripheral blood smear. If all this wasn’t bad enough, the thrombi can block blood flow to the liver, causing severe liver injury which can cause an elevation in liver enzymes.

Together all these make up HELLP syndrome, H for hemolysis, EL for elevated liver enzymes, and LP for low platelets. The damaged liver swells up and in some cases, as the condition worsens, the liver capsule may rupture leading to a subcapsular hematoma. This can present as right upper quadrant or epigastric pain. But if a lot of blood is lost, it can also lead to severe hypotension. Now, in other cases, HELLP syndrome can develop into disseminated intravascular coagulation, or DIC. That’s because damage to the endothelium can lead to the release of tissue factor, which triggers the coagulation cascade. And this, except for platelets which are already low, also depletes coagulation factors, making it even harder to establish hemostasis. This may present as bleeding from mucosal surfaces, intravenous lines or incision sites, if there are any. Now, what’s high-yield is that in terms of lab work, remember there’s decreased coagulation factors which means a prolonged prothrombin time, or PT, and prolonged partial thromboplastin time, or PTT. Another important hint is elevated d-dimer levels which come from clot lysis. So an individual with ΗΕLLP plus prolonged PT and PTT and elevated d-dimers is having DIC!

Finally, endothelial injury in preeclampsia increases vascular permeability, which is when water is allowed to slip out of blood vessels between neighboring endothelial cells and get into the tissues. Because there’s also a loss of protein from the blood due to the proteinuria, even more fluid moves from the blood vessels into the tissues. And this causes generalized edema which is often seen in the legs, face and hands; pulmonary edema which can cause cough and shortness of breath; and cerebral edema which can cause headache, confusion, and seizures. For your exams, what’s high-yield to remember is that when a female with preeclampsia develops seizures, we call it eclampsia.

Alright, now, let’s discuss treatment. The antihypertensive medications that can be used for chronic hypertension in pregnancy or gestational hypertension are hydralazine, methyldopa, labetalol, or nifedipine. To remember this, you can use the mnemonic Hypertensive Moms Love Newborns. In preeclampsia and eclampsia, in addition to antihypertensives, IV magnesium sulfate is also given to prevent or treat seizures. But since all of the problems of preeclampsia and eclampsia stem from placental dysfunction, it’s important to know that the definitive treatment is delivery of the fetus and placenta. Especially in the case of eclampsia or HELLP syndrome, delivery has to be immediate.

Okay, next, there is gestational trophoblastic disease, which includes both benign and malignant proliferations of placental or trophoblast cells. At the benign end of the spectrum, there’s molar pregnancy, which is also called hydatidiform moles. At the malignant end, there’s invasive moles, which can arise from benign moles and choriocarcinoma, which is placental cancer that most frequently occurs in the absence of a molar pregnancy.

Now, moles result from errors in normal fertilization. Normally, at fertilization, a single egg with 23 chromosomes fuses with a single sperm with 23 chromosomes, resulting in a new cell with 46 chromosomes. This can go wrong in two ways, so we have two kinds of moles: complete, or classic, and incomplete, or partial mole. Both lead to an abnormal proliferation of placental or trophoblast cells. The difference is that a complete mole appears when a chromosomally empty egg fuses with a normal sperm, and the sperm genetic material duplicates to form a 46 chromosome cell. However, it doesn’t have both maternal and paternal chromosomes, so the mole develops into a mass rather than developing into a fetus. An incomplete mole, on the other hand, appears when a normal egg is fertilized by two sperm - which forms an organism with 69 chromosomes, that usually develops into non-viable fetal parts.

What’s extremely high-yield is that with a complete mole, the placenta secretes a huge amount of hCG. So affected females initially present with signs of pregnancy, like missed periods. Vaginal bleeding is another sign, which may range from light spotting to heavy bleeding, and parts of the mole may even be eliminated, and they look like grapes, or cherry-like clusters. Additionally, for unclear reasons, this huge amount of hCG can lead to early preeclampsia, meaning hypertension and proteinuria before 20 weeks of gestation. Don’t confuse that with chronic hypertension, which is hypertension without proteinuria before 20 weeks of gestation. At the same time, excess hCG can lead to hyperemesis gravidarum, which is extreme nausea and vomiting which can lead to severe dehydration. Interestingly, hCG has a subunit that’s similar to TSH, so it can cause symptoms of hyperthyroidism, like insomnia, anxiety, tachycardia, and palpitations. Too much hCG can also result in the growth of theca lutein cysts in the ovaries, which can cause symptoms like pelvic pain or pressure on the affected side. Finally, since the mole grows much faster than a normal pregnancy would, a physical examination shows a uterus that’s too big for gestational age. Histologically, we’ll see fingerlike projections called chorionic villi which contain tiny arterioles and venules. Now, most villi will be hydropic, meaning swollen and edematous. And all around the villi, there’ll be diffuse and circumferential proliferation of large trophoblast cells. These can be either cytotrophoblasts with central nuclei and pale cytoplasm, or syncytiotrophoblasts that have multiple nuclei and darker cytoplasm. Another thing we can do is stain for the p57 protein. This is produced by a gene that’s only expressed on maternal cells. So a complete mole will stain negative for p57. Now, a very high yield test result you must remember is that a transvaginal ultrasound will show no fetal parts. Instead, there will be a diffuse echogenic pattern, called a “snowstorm” pattern, sometimes described as looking like a "clusters of grapes". This results from the presence of abnormal placental villi and blood clots that accumulate in the uterus. An incomplete mole also secretes more hCG than normal, but not quite as much as a complete mole. So while missed periods and vaginal bleeding are present, the uterus is not larger than expected for gestational age, and there are no symptoms of hCG hyperstimulation like early preeclampsia, hyperemesis gravidarum, hyperthyroidism, or ovarian cysts. On histological examination, we’ll also see villi, but, unlike complete moles, only some of them will be hydropic. Another key distinction is that p57 staining will be positive. On a transvaginal ultrasound, fetal parts will be visible.

Treatment for both complete and incomplete moles is uterine evacuation through suction curettage and methotrexate. Methotrexate is very frequently tested, so it’s important to know that it is an antimetabolite medication that is structurally similar to folic acid and is toxic to the rapidly dividing cells of the embryo. For your test, remember that it’s essential to monitor the hCG levels afterwards until they go back to normal. If that doesn’t happen, we can suspect an invasive mole or choriocarcinoma.

Okay, so, a high-yield fact is that both complete and incomplete moles are benign conditions, but can develop into malignant tumors, like invasive moles or, in rare cases, choriocarcinomas. In invasive moles, the villi invade deeper into the myometrium, which is the muscular wall of the uterus. In fact complete moles have a 15-20% risk of developing into invasive moles, whereas with incomplete moles, the risk is under 5%. However, it’s high-yield to know that most choriocarcinomas develop during or after a non-molar pregnancy. Broadly speaking, choriocarcinomas are usually quite small but if they get large enough, they can present with lower abdominal pain or pressure. They are also extremely aggressive, so they have a high chance of spreading via the circulation. A high-yield fact is that a very common location for metastasis is the lungs, causing shortness of breath and hemoptysis. On a chest x-ray, this shows up with the characteristic “cannonball metastases”. These are multiple, large, well-circumscribed, and round metastatic masses. Metastatic disease to the brain may also cause headache, dizziness, nausea, slurred speech or visual disturbances. Just like benign moles, choriocarcinomas also secrete hCG and this can cause symptoms of hyperthyroidism, as well as bilateral, multiple theca-lutein ovarian cysts. For your test, remember that under the microscope, choriocarcinomas look very similar to moles, so they have cytotrophoblasts and syncytiotrophoblasts. But the key distinction is that there are no villi. The main treatment is methotrexate. Alright, now let’s look at ectopic pregnancy. Normally, a fertilized egg travels through the fallopian tube and implants in the uterus, but in an ectopic pregnancy, the fertilized egg ends up implanting somewhere else. For your exams, remember that the most common site is the ampulla of the fallopian tube, but it can also occur on various surfaces, like the ovaries. The cause of an ectopic pregnancy is often unknown, but there are well known risk factors. A very high-yield one is pelvic inflammatory disease, since the inflammation results in scarring and adhesions, particularly in the fallopian tubes, thus, blocking the fertilized egg from traveling down into the uterus. Scar tissue can also build up in the fallopian tubes as a result of previous surgery involving the fallopian tubes, endometriosis, advanced age, and smoking, which is thought to damage the epithelium lining the fallopian tubes. The individual will frequently also have a history of prior ectopic pregnancy or infertility, which may indicate some anatomical abnormality of the fallopian tubes.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Greenspan's Basic and Clinical Endocrinology, Tenth Edition" McGraw-Hill Education / Medical (2017)
  5. "Diagnosing ectopic pregnancy and current concepts in the management of pregnancy of unknown location" Human Reproduction Update (2013)
  6. "Methotrexate for ectopic pregnancy: when and how" Archives of Gynecology and Obstetrics (2014)
  7. "Tubal ectopic pregnancy: diagnosis and management" Archives of Gynecology and Obstetrics (2008)